Order Processing Updates:
The Vaccines for Children (VFC) Program is currently not experiencing any delays in order review. Please note if you have an order in “Corrections Needed” status, review your order as soon as you have a chance and re-submit with corrections to prevent additional delays in fulfillment of your order. Providers can expect to receive their vaccines within 14 days after receiving the order processed notification. Please contact us at the VFC Customer Service Center if vaccines have not arrived within two weeks of your order processed confirmation.
As of 10/7, McKesson is caught up with order fulfillment and shipping on their normal cadence. If you have an approved order from the September 23, 2024 or earlier, and still have not yet received your shipment, please contact our VFC Customer Service Representatives at 877-243-8832. Thank you for your patience and understanding!
Regular Vaccine Supply Information:
Td Vaccine:
Until further notice, CDC has instituted temporary ordering controls to mitigate a supply constraint for Td vaccine. Once our allocation is exceeded for each month, Td vaccine will be unavailable to order until our allocation is refreshed the following month. Please remember to order and administer Tdap instead of Td whenever possible.
| BRAND | NDC | NDC Description | Currently Available? |
|---|---|---|---|
| TENIVAC | 49281-0215-15 | TD; 10-pack of syringes | Yes |
| TENIVAC | 49281-0215-10 | TD; 10-pack of single dose vials | Yes |
| TDVAX |
13533-0131-01 |
TD; 10-pack of single dose vials | Yes |
Hib Vaccine
As of February 20, 2024, Hiberix (NDC 58160-0818-11) is no longer available. The new presentation of Hiberix (NDC 58160-0726-15) will be available to order starting March 1, 2024. Alternate brands of Hib are still available to order (ActHIB and PedvaxHib).
RSV
Nirsevimab/Beyfortus™: Both 50 and 100 mg presentations are no longer available through the VFC Program. We expect to open up ordering in September. More information about RSV ordering and timelines will be communicated soon!
Abrysvo®: unavailable for ordering until the fall of 2024. Please store any remaining doses under appropriate storage conditions through the expiration date.
COVID-19 Vaccine:
2023-2024 COVID-19 vaccine is no longer available to order through the VFC Program. With the recent approval of new 2024-2025 mRNA COVID-19 vaccine formulations, we anticipate launch of the updated vaccine products during the week of September 2, 2024. We will send a separate communication to all VFC Providers once it is available to order
| Product | Age Group | Currently Available? |
| Pfizer (6m-4y) | 6 months – 4 years | No |
| Moderna (6m-11y) | 6 months – 11 years | No |
| Pfizer (5-11y) | 5 years – 11 years | No |
| Spikevax (Moderna) (12y+) | 12 years+ | No |
| Comirnaty (Pfizer) (12y+) | 12 years+ | No |
| Novavax | 12 years+ | No |
Pneumococcal Conjugate Vaccine
As of September 1, 2023, Prevnar 13 is no longer available. However, Prevnar 20 (NDC: 00005-2000-10) and Vaxneuvance (NDC: 00006-4329-03) are still available for ordering.
Meningococcal Vaccine:
As of August 9, 2024, MenQuadfi Single Dose Vials – 5 per box (NDC 49281-0590-05) presentation has been discontinued and is no longer available. An alternate presentation of MenQuadfi Single Dose Vials – 10 per box (NDC 49281-0590-10) is available.
As of September 1, 2023, the new Menveo one-vial is available for ordering through the VFC Program. However, the existing Menveo two-vial presentation will be available in limited amounts, and it will be important to target this product for use in children aged 2 months through 2 years of age at high risk for Meningococcal disease. This product is the only meningococcal conjugate vaccine approved for use in this age group. Requests for the limited Menveo two-vial vaccine will have a minimum order size of 1 dose with a maximum request of 5 doses.
As of June 2, 2022, Menactra has been discontinued and is no longer available. However, Menveo and MenQuadfi are available to order.
Rotavirus Vaccine:
As of March 6, 2023, ROTARIX (NDC 58160-0854-52, a vial and oral dosing applicator) is discontinued and no longer available. However, ROTARIX (NDC 58160-0740-21, an oral dosing applicator only presentation) is available to order.
Influenza Vaccine Supply Information:
The VFC Program has completed initial orders of all flu products. The Additional Flu Order system is now open so please continue to order flu doses throughout the season to protect your patients!
IMPORTANT: If your clinic will be closed, please notify the VFC Program immediately at 1-877-243-8832 to prevent any shipping incidents. Orders cannot be cancelled once they have been processed and shipments must not be refused when delivered!
| Products | Dose Volume | Age Group | Currently available? |
|---|---|---|---|
| Fluarix® pre-filled syringes, GSK | 0.5 mL | 6 months-18 years |
Yes |
| Flucelvax® pre-filled syringes, Seqirus | 0.5 mL | 6 months-18 years |
Yes |
| FluLaval® pre-filled syringes, GSK | 0.5 mL | 6 months-18 years |
Yes |
| Fluzone® pre-filled syringes, Sanofi | 0.5 mL | 6 months-18 years |
Yes |
| FluMist® pre-filled syringes, AstraZeneca | 0.2 mL | 2 years-18 years |
No |
PREVENT DELAYS:
- Login to myCAvax to verify that your clinic’s hours of operation are updated. This ensures a timely delivery of your vaccine shipments and prevents undeliverable shipment attempts which may lead to vaccine being spoiled.
Additional Resources
- Vaccine Management
- Storage and Handling Job Aids
- VFC Vaccine Orders
- VFC Influenza Vaccine
- VFC Vaccine Distribution